100+ Free TEGO (FEBRASGO / AMB) Practice Questions

Prepare for the Exame de Suficiência para Obtenção do Título de Especialista em Ginecologia e Obstetrícia (TEGO — FEBRASGO / AMB) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Brazilian Medical Association Specialty Title Concursos (AMB / Título de Especialista)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

CBR Prova de Título de Especialista em Radiologia e Diagnóstico por Imagem (Brazil)

Practice Questions100 questions

2026 Statistics

Key Facts: TEGO (FEBRASGO / AMB) Exam

120 Items

Multiple-choice questions in the 1ª Fase (60 Ginecologia + 60 Obstetrícia)

Edital TEGO 2026 — FEBRASGO

2 + 2 Hours

Two online papers with a 30-minute interval between them

Edital TEGO 2026 — FEBRASGO

70% Score

Minimum mark of 6,50 required in each 1ª Fase paper

Regulamento TEGO — FEBRASGO

50 / 50 Split

Equal Division (Gynecology & Obstetrics)

Matriz de Competências TEGO

2 Phases

Online 1ª Fase objective papers plus a presencial prova teórico-prática

Edital TEGO FEBRASGO / AMB

Lei 14.443/22

Brazilian Voluntary Sterilization Legal Framework

Presidência da República do Brasil

FIGO 2018/21

Gynecologic Oncology Staging Standard

International Federation of Gynecology and Obstetrics

INCA MS

Diretrizes Brasileiras de Rastreamento Cervical

Instituto Nacional de Câncer / Ministério da Saúde

The TEGO is the Brazilian board certification for OB/GYN specialists conferred by FEBRASGO and the AMB. Its 1ª Fase is applied online as two 2-hour papers — 60 questions in Ginecologia and 60 in Obstetrícia — each requiring a mark of at least 6,50, followed by a presencial prova teórico-prática in São Paulo. This bank is an English-language MCQ study adaptation of that syllabus, not a replica of the official paper.

Sample TEGO (FEBRASGO / AMB) Practice Questions

Try these sample questions to test your TEGO (FEBRASGO / AMB) exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1According to the Brazilian Ministry of Health (Ministério da Saúde) and FEBRASGO guidelines for Gestational Diabetes Mellitus (GDM / Diabetes Mellitus Gestacional), what is the diagnostic threshold when evaluating fasting plasma glucose (glicemia de jejum) in the first prenatal trimester?

A.A fasting plasma glucose value between 92 mg/dL and 125 mg/dL establishes the diagnosis of Gestational Diabetes Mellitus (GDM).

B.A fasting plasma glucose value of 100 mg/dL to 140 mg/dL is considered normal in the first trimester, requiring no further testing until the third trimester.

C.A fasting plasma glucose value >= 85 mg/dL is diagnostic of overt pre-existing diabetes mellitus (Diabetes Mellitus prévio à gestação).

D.Fasting plasma glucose is not recommended in the first trimester; only a random postprandial capillary blood glucose should be measured.

Explanation: According to FEBRASGO, the Brazilian Ministry of Health, and IADPSG criteria, a first-trimester fasting plasma glucose between 92 mg/dL and 125 mg/dL confirms Gestational Diabetes Mellitus (GDM). If fasting glucose is >= 126 mg/dL (or HbA1c >= 6.5%, or random glucose >= 200 mg/dL with symptoms), it is classified as Overt Diabetes (Diabetes Mellitus pré-gestacional). If fasting glucose is < 92 mg/dL, a 75g oral glucose tolerance test (TOTG 75g) is performed between 24 and 28 weeks.

2A 24-year-old primigravida at 14 weeks of gestation has a confirmed reactive VDRL titer of 1:32 and a positive treponemal test (FTA-ABS). She has no history of previous treatment or clinical lesions. According to the Brazilian Ministry of Health and FEBRASGO guidelines for gestational syphilis (Sífilis na Gestação), which treatment regimen constitutes adequate maternal and fetal therapy?

A.Oral Doxycycline 100 mg twice daily for 14 days, with sexual partner treatment being optional.

B.Benzathine Penicillin G (Benzilpenicilina benzatina) 2.4 million IU IM weekly for 3 consecutive weeks (total 7.2 million IU), with concurrent partner evaluation and treatment.

C.A single dose of oral Azithromycin 2 g, repeated after 14 days if the non-treponemal titer remains elevated.

D.Intravenous Ceftriaxone 1 g daily for 7 days followed by oral Erythromycin base for 30 days.

Explanation: In Brazil, gestational syphilis of late, latent, or unknown duration requires Benzathine Penicillin G 2.4 million IU (1.2 million IU in each buttock) IM once weekly for 3 consecutive weeks (total 7.2 million IU). Penicillin is the ONLY antibiotic proven to cross the placental barrier effectively to prevent and treat congenital syphilis. Non-penicillin regimens (e.g., ceftriaxone, erythromycin) are considered inadequate for congenital syphilis prevention under SUS guidelines.

3A 22-year-old pregnant woman presents at 9 weeks of gestation for her first prenatal visit. Serology for Toxoplasmosis reveals IgG positive (180 IU/mL) and IgM positive (Index 3.2). What is the next immediate and most appropriate step according to FEBRASGO protocols for maternal toxoplasmosis?

A.Reassure the patient that IgG positivity confirms long-standing immunity, requiring no further testing or follow-up.

B.Immediately start Sulfadiazine, Pyrimethamine, and Folinic Acid and perform an emergency hysterotomy.

C.Request an IgG Avidity Test (Teste de Avidez de IgG); if high avidity (> 60%) before 16 weeks, it indicates infection acquired prior to gestation, excluding acute congenital risk.

D.Initiate termination of pregnancy, as maternal IgM positivity during the first trimester invariably leads to fetal hydrops.

Explanation: When both IgG and IgM are positive in the first trimester (<= 16 weeks), an IgG Avidity Test must be requested immediately. A high-avidity result before 16 weeks confirms that infection occurred at least 3 to 4 months earlier (prior to conception), ruling out acute gestational toxoplasmosis and avoiding unnecessary treatment. If avidity is low or intermediate, Spiramycin (Espiramicina 1g TID) is started immediately, and amniocentesis for Toxoplasma PCR is scheduled at >= 18 weeks.

4Which of the following vaccines is officially recommended for ALL pregnant women in Brazil during EACH pregnancy, regardless of previous vaccination history, according to the National Immunization Program (PNI / Ministério da Saúde) and FEBRASGO?

A.Live attenuated Measles, Mumps, and Rubella (Tríplice Viral / MMR) vaccine.

B.Oral Poliovirus Vaccine (VOP / Sabin).

C.Yellow Fever (Febre Amarela) live attenuated vaccine at 12 weeks of gestation.

D.Adsorbed Diphtheria, Tetanus, and Acellular Pertussis vaccine (dTpa / Tríplice Bacteriana Acelular do Adulto) starting at 20 weeks of gestation.

Explanation: The dTpa vaccine (Diphtheria, Tetanus, acellular Pertussis) is recommended during every single pregnancy from the 20th gestational week onwards (ideally between 27 and 36 weeks) to induce maternal IgG antibodies that cross the placenta and provide passive neonatal immunity against pertussis (coqueluche) during the first months of life.

5Regarding universal screening and intrapartum chemoprophylaxis for Group B Streptococcus (GBS / Estreptococo do Grupo B - Streptococcus agalactiae) in obstetric care (FEBRASGO / CDC guidelines), which statement is correct?

A.Screening is performed via combined lower vaginal and rectal swab collected between 35+0 and 37+6 weeks of gestation.

B.Elective cesarean delivery performed before labor onset with intact membranes requires routine intrapartum GBS chemoprophylaxis.

C.A woman with a documented history of GBS bacteriuria in the current pregnancy still requires a 36-week rectovaginal swab before prophylaxis is decided.

D.Intrapartum chemoprophylaxis should be administered using oral Amoxicillin 500 mg every 8 hours throughout labor.

Explanation: Universal GBS screening is performed between 35+0 and 37+6 weeks of gestation using a single swab of the lower third of the vagina followed by the rectum (through the anal sphincter) without a speculum. Intrapartum IV prophylaxis (IV crystalline Penicillin G or Ampicillin) is administered at labor onset or membrane rupture. Prophylaxis is NOT indicated for planned cesarean delivery prior to labor with intact membranes.

6In obstetric ultrasound, which biometric parameter provides the most accurate estimation of gestational age during the first trimester (up to 13 weeks and 6 days)?

A.Biparietal Diameter (DBP / Diâmetro Biparietal).

B.Crown-Rump Length (CCN / Comprimento Cabeça-Nádega).

C.Femur Length (CF / Comprimento Femural).

D.Abdominal Circumference (CA / Circunferência Abdominal).

Explanation: Crown-Rump Length (CCN / CRL) measured between 9 and 13+6 weeks (corresponding to a CCN of approximately 10 mm to 84 mm) is the single most accurate ultrasound parameter for establishing gestational age, with a margin of error of only +/- 5 to 7 days.

7During the first-trimester morphological ultrasound screening (11+0 to 13+6 weeks), which set of sonographic findings carries the highest association with fetal aneuploidy (such as Trisomy 21 / Down Syndrome) and congenital heart defects?

A.Normal nuchal translucency (< 2.0 mm), visible nasal bone, and positive 'a' wave in the ductus venosus.

B.Presence of a single umbilical artery without any other structural or Doppler anomalies.

C.Increased Nuchal Translucency (Translucência Nucal >= 3.5 mm or > 95th percentile), absent nasal bone, and reversed 'a' wave in the Ductus Venosus Doppler.

D.Unilateral choroid plexus cyst measuring 3 mm with normal cardiac anatomy.

Explanation: Nuchal translucency (TN) >= 3.5 mm (or above the 95th percentile for CRL), absent fetal nasal bone, reversed 'a' wave (onda 'a' reversa) in ductus venosus Doppler, and tricuspid regurgitation are classic major first-trimester ultrasound markers for Down syndrome (Trisomy 21), Trisomy 18, Trisomy 13, Turner syndrome, and major congenital cardiac malformations.

8A 28-year-old pregnant woman at 30 weeks of gestation is being monitored for early-onset fetal growth restriction (CIUR precoce / FGR). Doppler evaluation shows reversed end-diastolic flow (diástole reversa) in the Umbilical Artery and a reversed 'a' wave (onda 'a' reversa) in the Ductus Venosus Doppler. What is the correct clinical interpretation and management according to FEBRASGO fetal medicine protocols?

A.Reversed flow in the ductus venosus indicates physiological compliance; outpatient monitoring with weekly Doppler is indicated.

B.Administer oral aspirin and dipyridamole to improve placental perfusion and re-evaluate in 4 weeks.

C.Initiate immediate high-dose oxytocin challenge test (teste de estresse com ocitocina) to assess suitability for prolonged vaginal labor.

D.The findings reflect severe fetal metabolic acidosis, myocardial dysfunction, and impending intrauterine death; after maternal stabilization, antenatal corticosteroid and immediate delivery are indicated.

Explanation: Reversed 'a' wave in the ductus venosus indicates severe right ventricular afterload, myocardial hypoxia, and impending fetal acidemia/death. In early-onset FGR, an abnormal ductus venosus 'a' wave is the single most critical trigger for delivery (after completing antenatal corticosteroids and magnesium sulfate for neuroprotection if < 32 weeks), regardless of low gestational age, because the risk of fetal death outweighs the risks of prematurity.

9According to the FIGO / FEBRASGO consensus on intrapartum Cardiotocography (CTG / Cardiotocografia basal e intraparto), which of the following trace descriptions represents a Category III (Abnormal / Patológica) tracing requiring immediate intrauterine resuscitation and rapid delivery?

A.Absent baseline variability accompanied by recurrent late decelerations (DIP II), recurrent variable decelerations (DIP III), or a sinusoidal pattern (padrão sinusoidal).

B.Baseline fetal heart rate of 130 bpm, moderate variability (6-25 bpm), presence of accelerations, and absence of decelerations.

C.Baseline fetal heart rate of 115 bpm with early decelerations (desacelerações precoces / DIP I) synchronous with uterine contractions.

D.Baseline fetal heart rate of 155 bpm with isolated variable decelerations lasting less than 30 seconds.

Explanation: According to FIGO and FEBRASGO guidelines, a Category III (abnormal/pathological) cardiotocography trace is characterized by absent baseline variability associated with recurrent late decelerations (DIP II / desacelerações tardias), recurrent variable decelerations (DIP III), prolonged bradycardia, or a persistent sinusoidal pattern (characteristic of severe fetal anemia/hypoxia). This indicates high risk of fetal hypoxia/acidosis requiring immediate intervention.

10During normal pregnancy, maternal cardiovascular physiology undergoes profound adaptations. Which of the following changes is considered a physiological maternal hemodynamic adaptation?

A.Marked decrease in maternal blood volume by 30% and increased systemic vascular resistance.

B.Increase in cardiac output (débito cardíaco) by 30% to 50%, reduction in systemic vascular resistance (RVS), and a physiological decrease in diastolic blood pressure reaching its nadir in the second trimester.

C.Significant elevation of resting mean arterial pressure by 25 mmHg during the second trimester.

D.Development of a loud diastolic decrescendo murmur over the aortic area.

Explanation: Normal gestational cardiovascular adaptations include a 30-50% increase in cardiac output (driven by stroke volume and resting heart rate), a significant decrease in systemic vascular resistance due to progesterone-mediated vasodilation and the low-resistance uteroplacental shunt, and a physiological decline in systolic and diastolic blood pressure, which reaches its lowest level (nadir) around 20-24 weeks of gestation.

About the TEGO (FEBRASGO / AMB) Exam

The Título de Especialista em Ginecologia e Obstetrícia (TEGO) is the official Brazilian board certification for obstetricians and gynaecologists, awarded by the Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO) in partnership with the Associação Médica Brasileira (AMB) and registered with the Conselho Federal de Medicina as an RQE. The examination covers modern obstetric and gynaecologic practice, maternal-fetal medicine, gynaecologic oncology, reproductive endocrinology, urogynaecology, mastology and family planning under Brazilian guidance (FEBRASGO, INCA, Ministério da Saúde/SUS). It runs in two stages: a 1ª Fase applied online carrying 60 multiple-choice questions in Ginecologia and 60 in Obstetrícia, and a presencial 2ª Fase prova teórico-prática in São Paulo. This module is an English-language multiple-choice study adaptation of the TEGO syllabus with full clinical rationales and distractor analyses, preserving official Portuguese terminology inline. It is not an official translation, an item replica or a simulation of the exam's format, and it cannot stand in for the teórico-prática stage.

Assessment

Two-phase examination run by FEBRASGO with the AMB. 1ª Fase, applied online on the eduCAT platform: 60 multiple-choice questions in Ginecologia (08h00–10h00) followed, after a 30-minute interval, by 60 multiple-choice questions in Obstetrícia (10h30–12h30). 2ª Fase: a presencial prova teórico-prática held in São Paulo for candidates called forward. Candidates who qualify for dispensation through their residency Teste de Progresso Individual (TPI) score may be exempted from the 1ª Fase.

Time Limit

1ª Fase: two 2-hour papers with a 30-minute interval between them

Passing Score

1ª Fase: a mark of at least 6,50 in EACH of the two papers; a mark below 6,50 in either paper eliminates the candidate

Exam Fee

R$ 4.600,00 (não sócio AMB ou FEBRASGO) / R$ 2.500,00 (sócio AMB) / R$ 2.500,00 (sócio FEBRASGO); with TPI dispensation from the 1ª Fase: R$ 3.780,00 (não sócio) / R$ 2.050,00 (sócio AMB ou FEBRASGO) (Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO) — AMB)

TEGO (FEBRASGO / AMB) Exam Content Outline

25%

Obstetrícia: Pré-natal, Fisiologia e Medicina Feto-Maternal

Encompasses routine low-risk and high-risk prenatal protocols, physiological maternal adaptations during gestation, routine laboratory screening, congenital infection diagnosis and management (syphilis, toxoplasmosis, HIV, CMV, Zika virus), Group B Streptococcus (GBS) screening and intrapartum chemoprophylaxis, maternal immunization schedules (dTpa, influenza, hepatitis B, COVID-19), ultrasound gestational dating, evaluation of fetal growth restriction (CIUR/FGR), and modern fetal vitality assessment including cardiotocography, fetal biophysical profile, and Doppler velocimetry of umbilical, middle cerebral, and uterine arteries and ductus venosus.

25%

Obstetrícia: Intercorrências Clínico-Obstétricas, Hemorragias, Parto e Puerpério

Evaluates diagnosis and management of hypertensive disorders of pregnancy (chronic hypertension, gestational hypertension, preeclampsia with and without severe features, eclampsia, HELLP syndrome, magnesium sulfate seizure prophylaxis using Pritchard and Zuspan regimens, and acute antihypertensive therapy), gestational diabetes mellitus (IADPSG/FEBRASGO criteria and insulin therapy), first-half obstetric hemorrhages (threatened, incomplete, complete, missed, and septic abortion; ectopic pregnancy medical and surgical management; hydatidiform mole and gestational trophoblastic disease), second-half hemorrhages (placenta previa, placenta accreta spectrum / PAS, placental abruption, uterine rupture, vasa previa), preterm labor tocolysis and antenatal corticosteroids, premature rupture of membranes (PPROM), labor mechanisms and FEBRASGO partogram interpretation, operative vaginal delivery (forceps and vacuum extraction), cesarean indications, postpartum hemorrhage (4Ts etiology, medical and surgical tamponade, B-Lynch sutures), and puerperal infections (endometritis).

25%

Ginecologia Geral, Infecções Pélvicas, Uroginecologia e Sangramento Uterino Anormal

Covers lower genital tract infections (bacterial vaginosis Amsel criteria, vulvovaginal candidiasis, trichomoniasis, chlamydial and gonococcal cervicitis), Pelvic Inflammatory Disease (PID/DIP Monif staging, outpatient and inpatient regimens), chronic pelvic pain and deep infiltrating endometriosis (clinical diagnosis, specialized transvaginal ultrasound, magnetic resonance imaging, medical and laparoscopic surgical management), adenomyosis, FIGO PALM-COEIN classification of abnormal uterine bleeding, uterine leiomyomas (FIGO submucosal, intramural, and subserosal classification and therapeutic algorithms), female urinary incontinence (stress urinary incontinence urodynamics and mid-urethral slings, overactive bladder / urgency incontinence pharmacological and behavioral therapy), and pelvic organ prolapse quantification (POP-Q staging and reconstructive surgery).

25%

Endocrinologia Ginecológica, Climatério, Oncologia Ginecológica, Mastologia e Contracepção

Focuses on amenorrhea evaluation algorithms (primary and secondary), Polycystic Ovary Syndrome (PCOS/SOP Rotterdam criteria and metabolic/ovulatory management), hyperprolactinemia, couple infertility basic investigation and assisted reproductive technology indications, climacteric syndrome and menopausal hormone therapy (window of opportunity, systemic vs transdermal estrogen, progestogen protection, absolute and relative contraindications), INCA Brazilian cervical cancer screening guidelines (cytology triennial protocols, DNA-HPV testing, colposcopic terminology and management of ASC-US, LSIL, ASC-H, HSIL, and AGC), FIGO staging and multidisciplinary treatment of cervical, endometrial, ovarian, and vulvar cancers, BI-RADS mammographic screening and classification, benign and malignant breast diseases, and WHO/FEBRASGO Medical Eligibility Criteria for Contraceptive Use (Categories 1–4, LARCs, combined hormonal contraceptives contraindications, and Brazilian Sterilization Law nº 14.443/2022).

How to Pass the TEGO (FEBRASGO / AMB) Exam

What You Need to Know

Passing score: 1ª Fase: a mark of at least 6,50 in EACH of the two papers; a mark below 6,50 in either paper eliminates the candidate
Assessment: Two-phase examination run by FEBRASGO with the AMB. 1ª Fase, applied online on the eduCAT platform: 60 multiple-choice questions in Ginecologia (08h00–10h00) followed, after a 30-minute interval, by 60 multiple-choice questions in Obstetrícia (10h30–12h30). 2ª Fase: a presencial prova teórico-prática held in São Paulo for candidates called forward. Candidates who qualify for dispensation through their residency Teste de Progresso Individual (TPI) score may be exempted from the 1ª Fase.
Time limit: 1ª Fase: two 2-hour papers with a 30-minute interval between them
Exam fee: R$ 4.600,00 (não sócio AMB ou FEBRASGO) / R$ 2.500,00 (sócio AMB) / R$ 2.500,00 (sócio FEBRASGO); with TPI dispensation from the 1ª Fase: R$ 3.780,00 (não sócio) / R$ 2.050,00 (sócio AMB ou FEBRASGO)

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

TEGO (FEBRASGO / AMB) Study Tips from Top Performers

1Master the Hypertensive Crisis & Magnesium Sulfate Protocols: Memorize the Zuspan (4g IV loading over 20 min + 1-2g/h maintenance IV) and Pritchard (4g IV + 10g IM loading [5g in each buttock] + 5g IM every 4h) protocols, clinical monitoring of toxicity (patellar reflex, respiratory rate >= 16 bpm, urine output >= 25-30 mL/h), and calcium gluconate antidote dosing.

2Memorize Gestational Diabetes Diagnostic Thresholds: Remember that under FEBRASGO/MS guidelines, a first-trimester fasting plasma glucose between 92 and 125 mg/dL establishes GDM. If normal (< 92 mg/dL), a 75g 2-hour OGTT performed between 24-28 weeks is diagnostic if ANY single value is met: Fasting >= 92 mg/dL, 1-hour >= 180 mg/dL, or 2-hour >= 153 mg/dL.

3Understand INCA Cervical Cancer Screening & Colposcopy Management: Follow the Brazilian flowchart strictly: Start at age 25 for sexually active women; repeat annually for 2 years, then every 3 years if normal until age 64. Know management of ASC-US (repeat in 6 months if >= 30y or in 12 months if 25-29y), LSIL (repeat in 6 months if >= 25y), and immediate colposcopy for HSIL, ASC-H, and AGC.

4Review WHO Contraceptive Eligibility Categories: Differentiate Category 4 (absolute contraindication, e.g., combined pills in migraine with aura, smoking >= 35 years and >= 15 cigarettes/day, active breast cancer, acute DVT/PE) from Category 3 (risks outweigh benefits) and Category 2/1 (safely usable).

5Analyze Postpartum Hemorrhage 4Ts & Shock Management: Know the sequential management for uterine atony (uterine massage, oxytocin 20-40 IU IV, ergometrine/methylergonovine [unless hypertensive], misoprostol 800 mcg rectally/sublingually, tranexamic acid 1g IV within 3h, Bakri intrauterine balloon, B-Lynch compressive suture, bilateral uterine/hypogastric artery ligation, and hysterectomy as last resort).

Frequently Asked Questions

What is the TEGO examination and who confers it?

The TEGO (Título de Especialista em Ginecologia e Obstetrícia) is the official Brazilian board certification for obstetricians and gynecologists. It is granted by the Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO) in association with the Associação Médica Brasileira (AMB) and officially recognized by the Conselho Federal de Medicina (CFM).

What is the format and structure of the TEGO examination?

The TEGO has two mandatory stages. The 1ª Fase is applied online on the eduCAT platform as two separate papers: 60 multiple-choice questions in Ginecologia from 08h00 to 10h00, then, after a 30-minute interval, 60 multiple-choice questions in Obstetrícia from 10h30 to 12h30. A candidate must score at least 6,50 in EACH paper; a mark below 6,50 in either one eliminates them. The 2ª Fase is a presencial prova teórico-prática held in São Paulo for candidates called forward. Candidates who qualify through their residency Teste de Progresso Individual score may be dispensed from the 1ª Fase at a reduced registration fee.

Which clinical guidelines and textbooks are prioritized in the TEGO exam?

The examination is strictly based on the official publications of FEBRASGO (Tratado de Obstetrícia FEBRASGO, Tratado de Ginecologia FEBRASGO, and Série Orientações FEBRASGO), official guidelines from the Brazilian Ministry of Health (Ministério da Saúde / SUS), INCA (Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero), and international consensus recognized in Brazil (such as FIGO oncology staging and WHO Contraceptive Eligibility Criteria).

Why is this question bank presented in English with Portuguese terminology?

This study tool is an English-language adaptation designed for international and bilingual medical test preparation. To preserve absolute clinical fidelity to Brazilian board standards, official Brazilian terms, legislative acts (e.g., Lei nº 14.443/2022), institutional names (FEBRASGO, AMB, INCA, SUS), clinical scores (Monif, Bishop, Rotterdam, IADPSG, PALM-COEIN), and drug protocols (Pritchard, Zuspan) are retained inline alongside comprehensive English clinical explanations.

What are the eligibility requirements to take the TEGO exam?

Candidates must hold a Medical Degree recognized by the Brazilian Ministry of Education (MEC), possess an active registration with a Regional Medical Council (CRM), and have completed an accredited Medical Residency in Gynecology and Obstetrics (CNRM/MEC) or have completed a FEBRASGO-accredited training program, or prove at least 6 years of documented clinical practice in the specialty.